MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2019 International Congress

    Improvement of Essential Tremor after Cortical Cerebral Infarction

    D. Riley (Warrensville Heights, OH, USA)

    Objective: To report a case of resolution of contralateral essential tremor (ET) after a cerebral cortical infarction. The restricted nature of the clinical and radiologic findings…
  • 2019 International Congress

    Tremoroton, a new open source tool for tremor analysis

    F. Vial, P. Kassavetis, M. Hallett (Bethesda, MD, USA)

    Objective: To introduce an open source software for the electrophysiological analysis of tremor. Background: The last MDS consensus on tremor in 2018 proposed a tremor…
  • 2019 International Congress

    Long-Term Outcomes with Valbenazine 40 mg/day in Adults with Tardive Dyskinesia

    S. Marder, C. Comella, C. Singer, C. Chepke, J. Burke, K. Farahmand, S. Siegert (Los Angeles, CA, USA)

    Objective: To examine long-term outcomes in adults with tardive dyskinesia (TD) who received once-daily valbenazine (VBZ) 40 mg or had a dose reduction from 80…
  • 2019 International Congress

    Subthalamic Nucleus of Luys: A review. What has evolved since 1865?

    G. Froehner, A. Meira, F. Germiniani, M. Meneses, R. Munhoz, H. Teive (Curitiba, Brazil)

    Objective: The review provides detailed material about the Subthalamic Nucleus of Luys, including pathophisiolgy, hystorical notes about Luys, embryology, anatomy, principal afferents and efferents pathways, as…
  • 2019 International Congress

    The effect of dopaminergic therapy on functional connectivity in patients with Parkinson’s disease and visual hallucinations

    A. Powell, J. Shine, S. Lewis (Sydney, Australia)

    Objective: To examine changes in functional connectivity in patients with Parkinson’s disease (PD) and visual hallucinations (VH) on and off dopaminergic medication. Background: Symptoms on…
  • 2019 International Congress

    Autonomic dysfunction in early Parkinson’s disease: a prospective study

    I. Stankovic, I. Petrovic, T. Pekmezovic, V. Markovic, T. Stojkovic, N. Dragasevic Miskovic, M. Svetel, V. Kostic (Belgrade, Serbia)

    Objective: To define prevalence, severity, and predictors of dysautonomia symptoms in patients with Parkinson's disease (PD) recruited at the Hoehn and Yahr stage 1 prospectively followed for three years.…
  • 2019 International Congress

    Cognitive and psychiatric course in the initial lustrum of Parkinson disease: the glass is half full

    D. Weintraub, C. Caspell-Garcia, H. Cho, T. Simuni, A. Siderowf, C. Coffey, D. Aarsland, R. Alcalay, L. Chahine, J. Eberling, A. Espay, J. Hamilton, J. Leverenz, I. Litvan, I. Richard, L. Rosenthal, M. York (Philadelphia, PA, USA)

    Objective: To describe the cognitive-psychiatric course in the first 5 years of diagnosed Parkinson disease (PD). Background: Although common, little is known about the differential…
  • 2019 International Congress

    Applicability of short form of Montreal Cognitive Assessment to Brazilian Portuguese

    M. Olchik, C. Rieder, L. Scudeiro, R. Millette, R. Rech, A. Ayres (Porto Alegre, Brazil)

    Objective: The aim of this study was to compare the efficiency  of the short form of Montreal Cognitive Assessment (s-MoCa) which has been validated in…
  • 2019 International Congress

    Resting-state EEG spectral power in Parkinson’s disease

    J. Dalrymple-Alford, R. Shoorangiz, E. Petersen, R. Jones, B. Elias, L. Livingston, I. Kirk, L. Tippett, M. Livingstone, T. Anderson (Christchurch, New Zealand)

    Objective: To examine the relationship between spectral power of resting state EEG (rsEEG) and cognition in Parkinson’s disease (PD). Background: Alzheimer patients have reduced rsEEG…
  • 2019 International Congress

    Neurocognitive changes post-bilateral globus pallidus interna DBS for Parkinson’s disease with autologous sural nerve graft to the substantia nigra or nucleus basalis of Meynert

    L. Koehl, E. Wallace, J. Quintero, F. Schmitt, C. van Horne (Lexington, KY, USA)

    Objective: To determine cognitive safety of globus pallidus interna (GPi) deep brain stimulation (DBS) in Parkinson’s disease (PD) patients receiving autologous sural nerve grafts to…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • …
  • 217
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley